01—Abstract
Summary
Summary of the 8-K filed April 24, 2024. Cited figures are marked; the original filing is the authoritative source.
CACI International Inc filed a Form 8-K on April 24, 2024, furnishing as Exhibit 99.1 a press release announcing its results for the fiscal 2024 third quarter ended March 31, 2024.
Revenues were $1.94 billiona, up 11.1% year over year and driven by 10 percent organic growth. Income from operations rose 16.9% to $181.3 million, net income rose 14.5% to $115.4 million, and diluted EPS rose 18.5% to $5.13. Adjusted diluted EPS, a non-GAAP measure that excludes intangible amortization, was $5.74, up 16.7%.
EBITDA margin was 11.3%, up 200 basis points sequentially. Contract awards totaled $3.5 billionb for the quarter, with about 46 percent for new business, and the company reported a book-to-bill of 1.8x. Total backlog reached $28.6 billion, a 13.0 percent increase from $25.3 billion a year earlier, while funded backlog was $3.2 billion, down 5.9 percent from $3.4 billion.
The company attributed the funded backlog decline to normal timing variation in funding and particularly strong funding in the prior-year quarter. CACI raised its fiscal 2024 guidance for revenue to $7,500 to $7,600 millionc from $7,300 to $7,500 million, and raised adjusted net income to $455 to $465 million and adjusted diluted EPS to $20.13 to $20.58. Free cash flow guidance was unchanged at at least $420 million.
The revenue guidance reflects approximately $200 milliond of higher-than-expected material purchases by customers, split evenly between the first and second quarters of fiscal 2024. Free cash flow for the quarter was $101.9 million, up 148.9% from $41.0 million, and days sales outstanding improved to 50 from 53.
02—Key points
Key Highlights
- Q3 FY2024 revenues of $1,937.5 million, up 11.1% year over year, including 10 percent organic growth
- Net income of $115.4 million (up 14.5%) and diluted EPS of $5.13 (up 18.5%); adjusted diluted EPS of $5.74 (up 16.7%)
- Contract awards of $3.5 billion with a book-to-bill of 1.8x; total backlog of $28.6 billion, up 13.0 percent
- Funded backlog of $3.2 billion, down 5.9 percent from $3.4 billion, attributed mainly to funding timing
- Fiscal 2024 revenue guidance raised to $7,500 to $7,600 million from $7,300 to $7,500 million; adjusted diluted EPS guidance raised to $20.13 to $20.58 from $19.91 to $20.58
- Free cash flow of $101.9 million for the quarter, up 148.9%; fiscal 2024 free cash flow guidance held at at least $420 million
- EBITDA margin of 11.3%, up 200 basis points sequentially; days sales outstanding improved to 50 from 53
03—Questions
Frequently Asked Questions
What drove the raised fiscal 2024 revenue guidance?
The filing states that the revenue guidance reflects approximately $200 million of higher-than-expected material purchases by customers, split evenly between the first and second quarters of fiscal 2024. Guidance also reflects lower diluted weighted average shares from earlier share repurchases.
How strong were new contract awards and backlog?
Third-quarter contract awards totaled $3.5 billion, with about 46 percent for new business to CACI, and the book-to-bill was 1.8x. Total backlog was $28.6 billion at March 31, 2024, compared with $25.3 billion a year earlier, an increase of 13.0 percent. Awards exclude ceiling values of multi-award IDIQ contracts.
Why did funded backlog decline?
Funded backlog was $3.2 billion compared with $3.4 billion a year earlier, a decrease of 5.9 percent. The company said the change was driven by normal variation in the timing of funding as well as particularly strong funding in the year-ago quarter.
How did cash generation compare with the prior year?
Free cash flow was $101.9 million for the quarter versus $41.0 million a year earlier, an increase of 148.9%. The company attributed the higher operating cash flow, excluding MARPA, to strong working capital and capital expenditure management and higher net income. Days sales outstanding improved to 50 from 53.
04—Continue